Literature DB >> 3632787

Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma.

A Tokumura, K Harada, K Fukuzawa, H Tsukatani.   

Abstract

A vasoactive lipid present in rat plasma that had been incubated at 37 degrees C for 48 h was identified as lysophosphatidic acid with the following fatty acid composition: palmitic acid (25.2%), stearic acid (8.4%), oleic acid (7.0%), linoleic acid (44.4%) and arachidonic acid (11.9%). The involvement of lysophospholipase D in the production of lysophosphatidic acid was suggested on the basis of extensive analyses of phospholipids in the plasma. Results indicated that lysophospholipase D hydrolyzed polyunsaturated lysophosphatidylcholines preferentially to the saturated species. Exogenously added platelet activating factor was found to be first converted to its lyso derivative by an acetylhydrolase in rat plasma and then degraded by lysophospholipase D to 1-alkyllysophosphatidic acid to a similar extent with exogenously added lyso derivative of platelet activating factor; their percent conversions to lysophosphatidic acid were higher than those of saturated 1-acyllysophosphatidylcholines, but lower than those of polyunsaturated 1-acyllysophosphatidylcholines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3632787

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.

Authors:  J S Saulnier-Blache; A Girard; M F Simon; M Lafontan; P Valet
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

3.  Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.

Authors:  Stéphane Gesta; Marie-Françoise Simon; Astrid Rey; David Sibrac; Alexia Girard; Max Lafontan; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

4.  Abnormal serum lysophospholipids in multiple myeloma patients.

Authors:  T Sasagawa; M Okita; J Murakami; T Kato; A Watanabe
Journal:  Lipids       Date:  1999-01       Impact factor: 1.880

5.  Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

Authors:  Akira Tokumura; Junya Sinomiya; Seishi Kishimoto; Tamotsu Tanaka; Kentaro Kogure; Takayuki Sugiura; Kiyoshi Satouchi; Keizo Waku; Kenji Fukuzawa
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes.

Authors:  A Nadal; E Fuentes; J Pastor; P A McNaughton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 7.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

8.  Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma.

Authors:  A Tokumura; M Miyake; O Yoshimoto; M Shimizu; K Fukuzawa
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

9.  Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Mauricio Rojas; Christopher End; Christopher Vallant; Anping Dong; Kevin Lynch; Jerold Chun; Andrew J Morris; Susan S Smyth
Journal:  Circ Res       Date:  2008-08-14       Impact factor: 17.367

10.  Lysophosphatidic acid possesses dual action in cell proliferation.

Authors:  G Tigyi; D L Dyer; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.